Six-Week, 6-Month, and 1-Year Self-Efficacy and Primary and Secondary Outcome Scores by Study Group
| Outcome | Home (n=138) | Telephone (n=139) | Usual Care (n=138) |
|---|---|---|---|
| CES-D = Center for Epidemiologic Studies Depression Scale, 10-item version; EQ-5D = EuroQol-5D; EQ VAS = EuroQol Visual Analog Scale; GH = SF-36 = Medical Outcomes Study 36-item short-form health survey (SF-36) general health subscale; HAQ = Health Assessment Questionnaire; MCS-36 = SF-36 mental component summary score; PCS-36 = SF-36 physical component summary score; PT/PP = pills taken/pills prescribed during the 7 days preceding data collection. | |||
| Intervention content delivery effectiveness | |||
| Self-efficacy score, mean (SD) | |||
| 6 Weeks | 7.6 (1.5) | 7.2 (1.8) | 7.2 (1.9) |
| 6 Months | 7.5 (1.6) | 7.2 (1.8) | 7.2 (1.7) |
| 1 Year | 7.4 (1.6) | 7.3 (1.7) | 7.2 (1.8) |
| Primary outcome | |||
| PCS-36 score, mean (SD) | |||
| 6 Weeks | 34.9 (11.9) | 36.3 (11.6) | 37.3 (11.1) |
| 6 Months | 36.2 (12.0) | 37.5 (11.8) | 37.2 (11.4) |
| 1 Year | 35.1 (12.2) | 36.4 (12.3) | 37.0 (11.6) |
| MCS-36 score, mean (SD) | |||
| 6 Weeks | 51.6 (12.1) | 48.9 (12.3) | 48.6 (12.8) |
| 6 Months | 49.6 (13.7) | 46.1 (13.6) | 48.0 (13.0) |
| 1 Year | 51.2 (12.1) | 48.3 (12.0) | 48.5 (12.9) |
| Secondary outcome | |||
| GH score, mean (SD) | |||
| 6 Weeks | 54.1 (21.4) | 54.4 (23.4) | 54.6 (25.0) |
| 6 Months | 53.8 (22.5) | 53.5 (23.5) | 54.4 (25.0) |
| 1 Year | 54.2 (23.1) | 54.3 (22.9) | 54.2 (24.1) |
| EQ-5D score, mean (SD) | |||
| 6 Weeks | 0.80 (0.17) | 0.80 (0.17) | 0.80 (0.17) |
| 6 Months | 0.82 (0.16) | 0.81 (0.18) | 0.80 (0.20) |
| 1 Year | 0.79 (0.18) | 0.77 (0.20) | 0.81 (0.17) |
| EQ VAS score, mean (SD) | |||
| 6 Weeks | 75.7 (18.5) | 73.5 (18.9) | 72.4 (19.7) |
| 6 Months | 74.6 (17.5) | 73.0 (20.4) | 72.9 (18.9) |
| 1 Year | 75.7 (15.2) | 72.3 (20.1) | 72.3 (18.9) |
| HAQ score, mean (SD) | |||
| 6 Weeks | 0.89 (0.70) | 0.84 (0.71) | 0.76 (0.64) |
| 6 Months | 0.88 (0.67) | 0.85 (0.74) | 0.80 (0.68) |
| 1 Year | 0.91 (0.71) | 0.85 (0.71) | 0.77 (0.64) |
| CES-D score, mean (SD) | |||
| 6 Weeks | 7.1 (6.0) | 7.6 (5.4) | 8.3 (6.5) |
| 6 Months | 7.5 (5.9) | 9.2 (6.5) | 8.2 (6.6) |
| 1 Year | 7.4 (6.3) | 8.6 (6.1) | 8.2 (6.9) |
| PT/PP, mean % (SD) | |||
| 6 Weeks | 93 (11) | 92 (15) | 93 (11) |
| 6 Months | 91 (16) | 89 (18) | 93 (13) |
| 1 Year | 94 (10) | 93 (12) | 91 (15) |
| Health care utilization at 1 year | |||
| Hospitalization, % | 16 (–) | 11 (–) | 15 (–) |
| Expenditures, $, mean (SD) | 14,105 (20,279) | 12,422 (14,241) | 11,493 (10,972) |